What Researchers Did
This retrospective study evaluated the effectiveness of COVID-19 preventive measures in a hyperbaric oxygen therapy center in Turkey between March and December 2020.
What They Found
Out of 122 patients who received hyperbaric oxygen (HBO) treatment, 5.7% (n=7) tested positive for SARS-CoV-2 during their treatment period, with 59.8% (n=73) considered at risk for severe clinical presentation. Additionally, two inside attendants (14.3%) were diagnosed with COVID-19, while the hyperbaric chamber was operated 608 times.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in a hyperbaric oxygen therapy center in Turkey.
Study Limitations
The study's retrospective, single-center design and limited duration may restrict the generalizability of its findings.